Federal Circuit Upholds Outcome Of Bench Trial In Antibiotic Patent Case
WASHINGTON, D.C. — A final judgment by a federal judge in Delaware directing the U.S. Food and Drug Administration to delay approval of generic rifaximin until three patents covering the antibiotic...To view the full article, register now.
Already a subscriber? Click here to view full article